Basis: FMP quote price / unrounded FMP forward EPS in the trading currency, available after its recorded retrieval time. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is N/A as of 2026-10-06T13:31:19.196Z.
Consensus retrieved: unavailable. This records retrieval, including cache reads, rather than vendor publication. The calculation uses the separately dated price and estimate available at its as-of time.
Calculation as of: 2026-10-06T13:31:19.196Z.
Quote observation: 2026-10-06T13:30:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 47abfa0c1c9b7ee8852b85727c09e566e291b91d06fb52154cb7b2e7f04347a4
FORWARD PE RATIO
N/A
Drugs Made In America Acquisition II Corp. Ordinary Shares
Market Cap
$649.74M
Forward PE Ratio
N/A
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Drugs Made In America Acquisition II Corp. Ordinary Shares (DMII) | $649.74M | N/A |
| ACNB Corporation (ACNB)vs › | $654.38M | 11.32 |
| Capital Bancorp, Inc. (CBNK)vs › | $655.76M | 11.58 |
| BlackRock Multi-Sector Income Trust (BIT)vs › | $641.96M | N/A |
| American Bitcoin Corp (ABTC)vs › | $639.48M | N/A |
| CoinShares PLC Ordinary Shares (CSHR)vs › | $635.18M | N/A |
| Hypoport SE (HYPOF)vs › | $630.67M | N/A |
| Gladstone Investment Corporation (GAINI)vs › | $671.96M | 25.38 |
| Donegal Group Inc. (DGICA)vs › | $673.17M | 10.15 |
| Carter Bankshares, Inc. (CARE)vs › | $674.84M | 5.04 |
Trailing P/E
34.8
reported TTM EPS
Forward P/E
N/A
consensus fiscal-year EPS
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
